BlogCOVID-19 and Sepsis: Risk-Stratifying Patients Based on Their Immune ResponseTimothy E. Sweeney, MD, PhD | February 26, 2021 Host-response diagnostics that “read” the immune response can help clinicians make better, faster treatment decisions
RegulatoryIVDR—The Impact of COVID-19Sherri Fraser, PhD | February 26, 2021 Industry concerns about IVDR implementation timelines
NewsNovel Pooled Testing Strategies Can Better Identify COVID-19 InfectionsHarvard T.H. Chan School of Public Health | February 26, 2021 The new approach to pooled COVID-19 testing could be an effective tool for curbing the SARS-CoV-2 pandemic
NewsReal-World Effectiveness of COVID-19 VaccineClalit Research Institute | February 25, 2021 First peer-reviewed real-world study of COVID-19 vaccine examined 600,000 vaccinated individuals
Industry NewsNew Robotic System for Ultra-High Throughput SARS-CoV-2 TestingZiath | February 24, 2021 A pioneering automated test robot, called STRIP-1, can process up to 20,000 SARS-CoV-2 samples in 24 hours
NewsPeople with SARS-CoV-2 Antibodies May Be Protected against ReinfectionNational Cancer Institute, National Institutes of Health | February 24, 2021 The new findings may explain why reinfection with the novel coronavirus appears to be relatively rare
NewsAbsence of Natural Killer Cell Receptor Associated with Severe COVID-19Medical University of Vienna | February 22, 2021 People with partial or total absence of the natural killer cell receptor are most likely to develop severe COVID-19
NewsDifferences in Antibody Response May Drive COVID-19 OutcomesMassachusetts General Hospital | February 19, 2021 Study identifies the specific types of antibodies that may be driving COVID-19 outcomes in both children and adults
NewsStudy Finds Negligible Detection of Coronavirus in Hematology/Oncology SettingsRutgers University | February 18, 2021 Researchers found extremely low detection of SARS-CoV-2 on surfaces across multiple outpatient and inpatient areas
NewsImmune System Protects Children from Severe COVID-19 Murdoch Children's Research Institute | February 17, 2021 Study finds children with COVID-19 have a more robust innate immune response to the virus compared to adults